Leider Harry L. 4/A
4/A · Organicell Regenerative Medicine, Inc. · Filed Dec 21, 2023
Insider Transaction Report
Form 4/AAmended
Leider Harry L.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-06-29$0.01/sh+500,000$5,000→ 1,049,450 total(indirect: See footnote) - Purchase
Common Stock
2023-06-28$0.01/sh+549,450$5,440→ 549,450 total(indirect: See footnote)
Footnotes (1)
- [F1]The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. The purpose of this Amendment is to correct the purchase price for the shares purchased on June 28, 2023.